Sandi, C., Pinto, R. M., Al-Mahdawi, S., Ezzatizadeh, V., Barnes, G., Jones, S., . . . Pook, M. A. (2011). Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model. Academic Press.

Sandi, Chiranjeevi, Ricardo Mouro Pinto, Sahar Al-Mahdawi, Vahid Ezzatizadeh, Glenn Barnes, Steve Jones, James R. Rusche, Joel M. Gottesfeld, and Mark A. Pook. Prolonged Treatment With Pimelic O-aminobenzamide HDAC Inhibitors Ameliorates the Disease Phenotype of a Friedreich Ataxia Mouse Model. Academic Press, 2011.

Sandi, Chiranjeevi, et al. Prolonged Treatment With Pimelic O-aminobenzamide HDAC Inhibitors Ameliorates the Disease Phenotype of a Friedreich Ataxia Mouse Model. Academic Press, 2011.